• Journal of Distribution Science
• /
• v.6 no.2
• /
• pp.41-60
• /
• 2008

This study examined state of local pharmaceuticals industry and investigated distribution system. The study found out associated problems as well as improvements of distribution system of local pharmaceuticals. Finally, to improve distribution system of local pharmaceuticals, the study investigated distribution system of 10 kinds of pharmaceuticals of 'J' Company being a leading local manufacturer of local pharmaceuticals, and found out improvements of the distribution system. The study collected and compiled 'J' Company's internal slips and reporting material from April 1, 2008 to July 31, 2008, and interviewed persons in charge continuously to find out state and problems of the distribution system.

• Journal of Technology Innovation
• /
• v.20 no.2
• /
• pp.135-159
• /
• 2012

To the analysis and discussion whether to conceptualization between the basis and LCM(Life cycle management) of patentability decisions and evergreening through research on patent application strategies and litigation cases. The Stakeholders have said that the LCM and evergreening strategies are an innovative effort to develop new pharmaceuticals, while others say that it is an effort to block generic pharmaceuticals from entering the market and permanently dominate the market by generic pharmaceuticals manufacturers or health economic perspectives. To achieve the goal of research, to discuss for conceptualization LCM and Evergreening strategies through patent application strategies for 14 pharmaceuticals for APIs and case studies for litigations. As a results, the LCM is getting patent rights for the results of research at the initial R&D stage and as such this shall be regarded as part of an effort for technology innovation. However, Evergreening is granting patent rights for the results by making high permission barrier to prevent the market entry of generic pharmaceuticals in the late development period during the pharmaceuticals development process or after their launch. This may lead to the problem of getting weak in health economic aspects and consumer welfare aspects by lowering the market accessibility of cheap generic pharmaceuticals.

• Proceedings of the Korea Crystallographic Association Conference
• /
• 2000.05a
• /
• pp.10-10
• /
• 2000

No Abstract, See Full-text

• Proceedings of the PSK Conference
• /
• 2002.04a
• /
• pp.214.3-215
• /
• 2002

• Journal of Korean Society of Environmental Engineers
• /
• v.37 no.3
• /
• pp.182-190
• /
• 2015

This study was conducted to evaluate the removal efficiencies of organic matter and pharmaceuticals and to identify the removal mechanism of pharmaceuticals using sand obtained from Hwangryong River in Jangsung. Batch and column studies were used to simulate managed aquifer recharge (MAR) systems. All experiments were performed using field effluent containing pharmaceuticals from Damyang Wastewater Treatment Plant as an influent. Based on the removal results of organic matter and pharmaceuticals from the batch and column experiments, soil organic matter (SOM) and microbial activity were found to effectively remove target contaminants. The removal of organic matter was found to increase under biotic conditions. Neutral and cation pharmaceuticals (iopromide, estrone, and trimethoprim) exhibited removal efficiencies higher than 70% from natural sand and baked sand media in batch and column studies. Carbamazepine persisted in the sand batch and column studies. Anion pharmaceuticals (ketoprofen, ibuprofen, and diclofenac) can be removed under conditions featuring high SOM and adenosine triphosphate (ATP) concentrations in the sand surface. Based on the experimental Batch and column results, biodegradation and sorption were found to be important mechanisms for the removal of pharmaceuticals within the simulated MAR systems.

• Bulletin of the Korean Chemical Society
• /
• v.31 no.5
• /
• pp.1192-1198
• /
• 2010

Pharmaceuticals and personal care products (PPCPs) are emerging contaminants in the aquatic environment. Many pharmaceuticals are not completely removed during wastewater treatment, leading to their presence in wastewater treatment effluents, rivers, lakes, and ground water. Here, we developed analytical methods for monitoring ten pharmaceuticals from surface water by LC/ESI-MS/MS. For sample clean-up and extraction, MCX (mixed cation exchange) and HLB (hydrophilic-lipophilic balance) solid-phase extraction (SPE) cartridges were used. The limits of detection (LOD) in distilled water and the blank surface water were in the range of 0.006 - 0.65 and 1.66 - 45.05 pg/mL, respectively. The limits of quantitation (LOQ) for the distilled water and the blank surface water were in the range of 0.02 - 2.17 and 5.52 - 150.15 pg/mL, respectively. The absolute recoveries for fortified water samples were between 62.1% and 125.4%. Intra-day precision and accuracy for the blank surface water were 2.9% - 24.1% (R.S.D.) and -16.3% - 16.3% (bias), respectively. In surface wastewater near rivers, chlortetracycline and acetylsalicylic acid were detected frequently in the range of 0.017 - 5.404 and 0.029 - 0.269 ng/mL, respectively. Surface water near rivers had higher levels than surface water of domestic treatment plants.

• Toxicological Research
• /
• v.17
• /
• pp.201-203
• /
• 2001

The Japan Pharmaceutical Manufacturers Association. with the cooperation of the Japan Association of Contract Laboratories for Safety Evaluation. launched a collaborative study with 38 companies aimed at elucidating the correlation between histopathological/hematological findings and immune function. Seven substances were individually administered to Crj : CD (SD)IGS rats for 14 or 28 days. Their immunotoxicity was assessed by histopathology. hematology. plaque-forming cell assay. enzyme-linked immunosorbent assay of serum antibody to sheep red blood cells. and flow cytometry. Appropriate procedures for immunotoxicology evaluation of pharmaceuticals were considered.

• YAKHAK HOEJI
• /
• v.12 no.1_2
• /
• pp.35-39
• /
• 1968

Alkalinity of pharmaceutical containers is to be highly influenced for liquid pharmaceuticals. The criteria of the alkalinity of ampoules and vials used as pharmaceutical containers is established in the Korean Pharmacopoeia. However, the criteria of general containers for liquid pharmaceuticals is not eatablished in the Korean Pharmacopoeia. Therefore, we tried to perform comparing test for domestic products and foreign products of following group: 1) vials 2) general containers for liquid pharmaceutical 3) general containers for tablet pharmaceuticals It was found that the domestically produced vials were good enough for criteria, while almost fifty percent of non-established containers was unsaticefactory.

• Journal of Plant Biotechnology
• /
• v.37 no.1
• /
• pp.67-71
• /
• 2010

Output traits centered on improved plant-based products will find their way to consumers in such ways as nutritionally enhanced foods, therapeutic proteins for disease treatment and vaccines, bio-industrial products, modified oil quality and biofuels. Significant progress in biotechnology has occurred over the last several decades. The importance of output traits development and production using biotechnology will impact not only agribusiness, but also pharmaceutical and food industries. The objective of this paper is to review briefly the current status of output traits development in crop plants using nutrients and pharmaceuticals as examples.

• Journal of Pharmaceutical Investigation
• /
• v.4 no.1_2
• /
• pp.13-18
• /
• 1974

Data are present for the interaction of beta-cyclodextrin with 7 pharmaceuticals in aqueous solution. By means of the solubility method of analysis, definite interaction were found to occur with all the compounds tested. The amount of these pharmaceuticals in equilibrium with their respective solid phase increased progressively with beta-cyclodextrin. A concentration of 1.5 g of beta-cyclodextrin per 100 ml of water increased the solubility of most compounds tested (except one) by 15-120%. Hydrolysis in alkali solution of chrolothiazide was retarded in the presence of beta-cyclodextrin.